Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0280
0.00 (0.00%)
At close: Jun 24, 2025

SGXC:9G2 Statistics

Total Valuation

SGXC:9G2 has a market cap or net worth of SGD 29.35 million. The enterprise value is 78.84 million.

Market Cap 29.35M
Enterprise Value 78.84M

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date Oct 29, 2025
Ex-Dividend Date n/a

Share Statistics

SGXC:9G2 has 1.05 billion shares outstanding. The number of shares has increased by 55.94% in one year.

Current Share Class 1.05B
Shares Outstanding 1.05B
Shares Change (YoY) +55.94%
Shares Change (QoQ) n/a
Owned by Insiders (%) 18.31%
Owned by Institutions (%) 9.38%
Float 283.05M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.82
PB Ratio 0.42
P/TBV Ratio 0.42
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -2.73
EV / Sales 4.89
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -5.41

Financial Position

The company has a current ratio of 0.45, with a Debt / Equity ratio of 0.79.

Current Ratio 0.45
Quick Ratio 0.42
Debt / Equity 0.79
Debt / EBITDA n/a
Debt / FCF -3.77
Interest Coverage -5.77

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -17.63%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -74.07% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -74.07%
50-Day Moving Average 0.04
200-Day Moving Average n/a
Relative Strength Index (RSI) 38.83
Average Volume (20 Days) 168,170

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SGXC:9G2 had revenue of SGD 16.14 million and -28.87 million in losses. Loss per share was -0.03.

Revenue 16.14M
Gross Profit 7.73M
Operating Income -20.99M
Pretax Income -28.87M
Net Income -28.87M
EBITDA -11.47M
EBIT -20.99M
Loss Per Share -0.03
Full Income Statement

Balance Sheet

The company has 5.37 million in cash and 54.86 million in debt, giving a net cash position of -49.50 million or -0.05 per share.

Cash & Cash Equivalents 5.37M
Total Debt 54.86M
Net Cash -49.50M
Net Cash Per Share -0.05
Equity (Book Value) 69.14M
Book Value Per Share 0.07
Working Capital -9.15M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.17 million and capital expenditures -392,599, giving a free cash flow of -14.56 million.

Operating Cash Flow -14.17M
Capital Expenditures -392,599
Free Cash Flow -14.56M
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 47.88%, with operating and profit margins of -130.05% and -178.93%.

Gross Margin 47.88%
Operating Margin -130.05%
Pretax Margin -178.89%
Profit Margin -178.93%
EBITDA Margin -71.08%
EBIT Margin -130.05%
FCF Margin n/a

Dividends & Yields

SGXC:9G2 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -55.94%
Shareholder Yield n/a
Earnings Yield -98.39%
FCF Yield -49.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SGXC:9G2 has an Altman Z-Score of -0.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.89
Piotroski F-Score 3